Library
  • Behind the Science
  • Science Innovation
    • Vapor
    • Modern Oral
    • Traditional Oral
  • Scientific Assessment
    • Emission Studies
    • Exposure Studies
    • Risk Studies
  • Science Engagement & Communication
    • Publications
    • Conferences
    • Our Scientists
  • Library
  • Behind the Science
  • Science Innovation
    • Vapor
    • Modern Oral
    • Traditional Oral
  • Scientific Assessment
    • Emission Studies
    • Exposure Studies
    • Risk Studies
  • Science Engagement & Communication
    • Publications
    • Conferences
    • Our Scientists
  • Library

Archives: Conference

In Vitro Cytotoxicity Assessment of 3D Human Airway Tissue Following Exposure to Whole Aerosol/Smoke Generated from Electronic and Combustible Cigarettes

June 7, 2022

By priceweber

Biomarkers of Potential Harm in Smoking Abstinence and in the Use of Vuse Electronic Nicotine Delivery Systems (ENDS)

June 7, 2022

By priceweber

Assessment of in vitro toxicities demonstrated by total particulate matter (TPM) generated from current market and research reference standard cigarettes using the Bhas-42 Promotor Cell Transformation Assay

June 7, 2022

By priceweber

Analysis of (S)- and (R)-Nicotine in Commercial Nicotine Samples and E-liquids Analysis of (S)- and (R)-Nicotine in Commercial Nicotine Samples and E-liquids Pharmacology

June 7, 2022

By priceweber

Analysis of (S)- and (R)-Nicotine in Commercial Nicotine Samples and E-liquids

June 7, 2022

By priceweber

ENDS Topography Across Multiple Platforms in an Ambulatory Setting

June 7, 2022

By priceweber

Correlation of NNK levels in tobacco and moist snuff with the levels of pseudooxynicotine and nicotine-1-N-oxide

June 7, 2022

By priceweber

Nrf2 Response to Whole Smoke and Aerosol of Two Different Tobacco Product Types in a 3D Human Airway Model

June 7, 2022

By priceweber

Ambulatory Use of Electronic Nicotine Delivery Systems – Redefining Topography Endpoints

June 7, 2022

By priceweber

Abuse Liability Evaluation of Velo Oral Nicotine Products Compared to Combustible Cigarettes and NRT Gum in Adult Smokers

June 7, 2022

By priceweber

Posts navigation

Older posts
Newer posts
Science Innovation Scientific Assessment Science Engagement & Communication
Our Scientists Conferences Publications

This website is intended for scientists and policymakers. We encourage persons interested in tobacco harm reduction to consider all points of view and sources of information. Reynolds does not make health claims regarding its brands. Nothing contained here should be misconstrued to the contrary. To the extent that third-party sources are referenced, Reynolds is not responsible for the content of referenced sources and the views expressed may not represent the views of Reynolds. No tobacco product is safe, all tobacco products containing nicotine are addictive. Youth should never use tobacco. Smokers who are concerned about their health should quit.
Reynolds American Inc. is the U.S. parent company of, among others, R. J. Reynolds Tobacco Company; Santa Fe Natural Tobacco Company, Inc.; American Snuff Company, LLC; R. J. Reynolds Vapor Company; Modoral Brands Inc.; RAI Services Company; and Reynolds Marketing Services Company. All subsidiaries operate and conduct separate, distinct businesses. References to “Reynolds,” “the group,” “the company,” “we,” “us,” and “our” are simply for convenience and may be used to refer to Reynolds American Inc. and/or one of its independent subsidiary operating companies, collectively or individually, and are not intended to imply or suggest that the subsidiaries’ businesses are operated other than as separate, distinct businesses. Activities among affiliate companies are covered through intercompany services agreements with arm's-length terms and conditions.

© 2025 RAISC

Terms of Use Privacy Policy